Internal Medicine, Infectious Disease · New York, NY
NPI
1376634915
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
251 E 33rd St, Suite 1n
New York, NY, 10016
Phone (212) 213-0800
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
1,468 services
Medicare patients, 2024
220
Average age 75
Drug cost, 2024
$922K
4,860 prescriptions
Company payments, 2025
$2,641
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yevgeniya Kaykova was code 99214 (office e&m - established), 806 times for 199 patients. In total Yevgeniya Kaykova billed 1,468 services in 21 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 806 | 199 | $103.69 | $84K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 138 | 138 | $144.00 | $20K |
| 99215 Office E&M - Established | Office | 116 | 69 | $149.38 | $17K |
| 99213 Office E&M - Established | Office | 93 | 52 | $79.95 | $7,435 |
| 93000 Electrocardiogram | Office | 62 | 57 | $11.60 | $719 |
| G0008 Administration of influenza virus vaccine | Office | 43 | 43 | $36.26 | $1,559 |
| 90662 Vaccine Product | Office | 42 | 42 | $81.82 | $3,436 |
| 99204 Office E&M - New | Office | 21 | 21 | $141.42 | $2,970 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 17 | 15 | $47.72 | $811 |
| 94060 Pulmonary Function Testing | Office | 12 | 12 | $35.14 | $422 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 11 | 11 | $182.75 | $2,010 |
By year: 2022 $156K for 1,521 services; 2023 $150K for 1,519 services; 2024 $143K for 1,468 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yevgeniya Kaykova prescribed most often to Medicare patients was Amlodipine Besylate, with 225 prescriptions and refills. In total Yevgeniya Kaykova wrote 4,860 Medicare prescriptions that cost $922K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 225 | 570 | 62 | $1,230 |
| Atorvastatin Calcium Generic | 149 | 405 | 45 | $1,174 |
| Losartan Potassium Generic | 124 | 320 | 34 | $1,211 |
| Levothyroxine Sodium Generic | 123 | 320 | 35 | $1,491 |
| Rosuvastatin Calcium Generic | 121 | 317 | 40 | $1,601 |
| Metoprolol Succinate Generic | 108 | 270 | 35 | $1,684 |
| Diclofenac Sodium Generic | 91 | 107 | 19 | $2,262 |
| Zolpidem Tartrate Generic | 84 | 84 | 17 | $399 |
| Hydrochlorothiazide Generic | 79 | 175 | 21 | $271 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 79 | 94 | 18 | $2,866 |
| Gabapentin Generic | 78 | 154 | 24 | $911 |
| Metformin Hcl Generic | 78 | 210 | 22 | $613 |
| Pravastatin Sodium Generic | 73 | 186 | 21 | $903 |
| Azithromycin Generic | 69 | 69 | 53 | $185 |
| Fluticasone Propionate Generic | 63 | 84 | 23 | $549 |
Brand drugs: 824 claims; generic drugs: 3,982 claims; opioid claims: 95.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yevgeniya Kaykova $2,641 ($2,641 in general payments such as food, travel and fees) from 13 companies. The largest payer was Gilead Sciences, Inc. with $687.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 29 | $687 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $457 |
| Novo Nordisk Inc NVO | 12 | $327 |
| ViiV Healthcare Company GSK | 12 | $320 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $258 |
| Abbvie Inc. ABBV | 10 | $208 |
| Lundbeck LLC | 9 | $156 |
| Pfizer Inc. PFE | 4 | $86.42 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $54.47 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $22.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.